ALK – Financial calendar for the 2022 financial year

2022 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF):

Silent period	11 January 2022
Annual report 2021	8 February 2022
Annual General Meeting to be held at ALK Bøge Allé 1 2970 Hørsholm, Denmark Written requests to have specific business transacted at the AGM will be included in the agenda if received by the company on 1 February 2022 at the latest (may be e-mailed to investor@alk.net)	16 March 2022 4.00 p.m.
Silent period	14 April 2022
Three-month interim report (Q1) 2022	12 May 2022
Silent period	14 July 2022
Six-month interim report (Q2) 2022	11 August 2022
Silent period	13 October 2022
Nine-month interim report (Q3) 2022	10 November 2022

ALK-Abelló A/S

For further information please contact:

Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525

Media: Jeppe Ilkjær, mobile +45 3050 2014

About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,600 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.

Attachment

• InvestorNews_16Dec21